FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

125706008: Sodium benzoate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
194194012 Sodium benzoate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
729566014 Sodium benzoate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
911591000195119 benzoato di sodio it Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
21061000188110 sodium benzoate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
840651000172111 benzoate de sodium fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sodium benzoate Is a médicament divers false Inferred relationship Some
Sodium benzoate Is a Food preservative true Inferred relationship Some
Sodium benzoate Is a Sodium compound true Inferred relationship Some
Sodium benzoate Is a Benzoate derivative (substance) false Inferred relationship Some
Sodium benzoate Is a Food allergen false Inferred relationship Some
Sodium benzoate Is a Food pseudoallergen false Inferred relationship Some
Sodium benzoate Is a Benzoate true Inferred relationship Some
Sodium benzoate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Benzoic acid (substance) false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Sodium benzoate-induced angioedema-urticaria (disorder) Causative agent (attribute) True Sodium benzoate Inferred relationship Some 2
Caffeine and sodium benzoate injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sodium benzoate Inferred relationship Some
Product containing sodium benzoate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sodium benzoate Inferred relationship Some 1
Product containing caffeine and sodium benzoate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sodium benzoate Inferred relationship Some 1
Product containing sodium benzoate and sodium phenylacetate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sodium benzoate Inferred relationship Some 2
Sodium benzoate 100 mg/mL and sodium phenylacetate 100 mg/mL solution for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sodium benzoate Inferred relationship Some
Caffeine- and sodium benzoate-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sodium benzoate Inferred relationship Some 1
Caffeine and sodium benzoate only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sodium benzoate Inferred relationship Some 1
Product containing only sodium benzoate and sodium phenylacetate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sodium benzoate Inferred relationship Some 2
Product containing only sodium benzoate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sodium benzoate Inferred relationship Some 1
Product containing only caffeine and sodium benzoate in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sodium benzoate Inferred relationship Some 1
Sodium benzoate- and sodium phenylacetate-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sodium benzoate Inferred relationship Some 2
Product containing only sodium benzoate and sodium phenylacetate in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sodium benzoate Inferred relationship Some 2
Sodium benzoate 100 mg/mL and sodium phenylacetate 100 mg/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sodium benzoate Inferred relationship Some 2
Sodium benzoate 100 mg/mL and sodium phenylacetate 100 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sodium benzoate Inferred relationship Some 2
Sodium benzoate-induced angioedema-urticaria (disorder) Causative agent (attribute) True Sodium benzoate Inferred relationship Some 1

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start